Healthy Upside Potential: Xeris Biopharma Holdings Inc (XERS)

With 5.21 million shares changed hands, the volume of the stock remained heavier than its average volume of 3.12 million shares. The 52-week range on XERS shows that it touched its highest point at $6.07 and its lowest point at $1.72 during that stretch. It currently has a 1-year price target of $6.25. Beta for […]

Prepare Yourself for Liftoff: Xeris Biopharma Holdings Inc (XERS)

With 1.7 million shares changed hands, the volume of the stock remained lighter than its average volume of 3.05 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $4.51 whereas the lowest price it dropped to was $4.35. The 52-week range on XERS shows […]

Xeris Biopharma Holdings Inc (XERS) expanding its growth trajectory ahead

With 6.59 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.96 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $4.89 whereas the lowest price it dropped to was $4.5001. The 52-week range on XERS shows […]